KLOW 80mg

Two mechanisms. One vial. BPC-157 drives repair at the site of damage. GHK-Cu resets the cellular environment it happens in.

$ 349.00

Personalized guidance 1 on 1

Full refund if our licensed clinician determines the treatment isn’t a fit for you

MOA

Overview

KLOW is Helyxlab’s proprietary 80mg research blend combining BPC-157 and GHK-Cu in a single lyophilised vial. These two compounds were selected together because their mechanisms are non-overlapping — they address different levels of the same biological goal. BPC-157 targets the acute, local, structural conditions at the site of damage. GHK-Cu targets the broader cellular and genetic environment across multiple systems simultaneously. One creates the conditions for repair. The other amplifies and sustains the capacity to carry it out.

What it does

BPC-157 drives angiogenesis and collagen synthesis acutely — increasing blood supply, growth hormone receptor expression in fibroblasts, and structural repair signalling at the administration site. GHK-Cu simultaneously shifts the expression of 4,000+ genes toward regeneration — upregulating collagen production, fibroblast activity, anti-inflammatory pathways, antioxidant defences, and DNA repair while downregulating pro-inflammatory and pro-fibrotic gene expression. Administered together, they operate in parallel rather than in competition — the acute structural driver and the systemic cellular reset, in a single injection.

Research areas

Acute musculoskeletal injury — tendon, ligament, muscle, joint · Gastrointestinal repair and gut lining integrity · Post-injury and post-procedure recovery research · Skin and connective tissue regeneration · Anti-aging and systemic cellular regeneration · Chronic inflammatory conditions research

Key facts

Form	Lyophilised powder — 80mg combined blend. Requires reconstitution with bacteriostatic water
Storage	Lyophilised: -20°C, stable up to 2 years. Reconstituted: 2–8°C, use within 14 days
Purity	≥99% — third-party COA verified, batch-specific documentation included per component
Blend composition	BPC-157 (Body Protection Compound-157) + GHK-Cu (Copper Tripeptide-1) + TB-500 + KPV

For research use only. Not for human consumption. This product is not approved for human use by the FDA or any regulatory body.

More Information

All products offered on this website are intended solely for laboratory research and development purposes. They are not approved for human or veterinary use.

Statements on this site have not been evaluated by the U.S. Food and Drug Administration (FDA). Products are not intended to diagnose, treat, cure, mitigate, or prevent any disease.

Products are manufactured in U.S.-based facilities operating under applicable cGMP standards. This website does not operate as a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act.

A valid health screening is required prior to order fulfillment. After checkout, you will receive instructions to complete the required intake process. Orders will be processed once the screening has been completed and approved. Each completed screening remains valid for 12 months.